Science Pool

Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes

Evotec SE announced today that the Company has received a US$ 2.5 m grant from the Bill & Melinda Gates Foundation (“the foundation”) for its teratogenicity platform, and joins the foundation’s prestigious Global Health Discovery Collaboratory (“GHDC”), a network of researchers, centres of excellence, and technology platforms working together to accelerate the discovery and translation of global health interventions.

Read More

Twitter
LinkedIn
Email